These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 3488514

  • 1. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors.
    Starr BS, Starr MS.
    Neuropharmacology; 1986 May; 25(5):455-63. PubMed ID: 3488514
    [Abstract] [Full Text] [Related]

  • 2. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
    Starr BS, Starr MS.
    Neuropharmacology; 1987 Jun; 26(6):613-9. PubMed ID: 2955244
    [Abstract] [Full Text] [Related]

  • 3. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS, Starr MS, Kilpatrick IC.
    Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
    [Abstract] [Full Text] [Related]

  • 4. Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390.
    Starr BS, Starr MS.
    Pharmacol Biochem Behav; 1986 Apr; 24(4):837-9. PubMed ID: 2940604
    [Abstract] [Full Text] [Related]

  • 5. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [Abstract] [Full Text] [Related]

  • 6. Effects of dopamine D1 and D2 receptor agonists and antagonists on bombesin-induced behaviors.
    Merali Z, Piggins H.
    Eur J Pharmacol; 1990 Dec 04; 191(3):281-93. PubMed ID: 2086245
    [Abstract] [Full Text] [Related]

  • 7. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
    Meller E, Bordi F, Bohmaker K.
    Life Sci; 1988 Dec 04; 42(25):2561-7. PubMed ID: 3260320
    [Abstract] [Full Text] [Related]

  • 8. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Lublin H, Gerlach J, Peacock L.
    Clin Neuropharmacol; 1992 Dec 04; 15(6):448-58. PubMed ID: 1362136
    [Abstract] [Full Text] [Related]

  • 9. CY 208-243 behaves as a typical D-1 agonist in the reserpine-treated mouse.
    Abbott B, Starr BS, Starr MS.
    Pharmacol Biochem Behav; 1991 Feb 04; 38(2):259-63. PubMed ID: 1676166
    [Abstract] [Full Text] [Related]

  • 10. SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors.
    Fletcher GH, Starr MS.
    Eur J Pharmacol; 1985 Nov 19; 117(3):381-5. PubMed ID: 3878300
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit.
    Ongini E, Caporali MG.
    Neuropharmacology; 1987 Apr 19; 26(4):355-60. PubMed ID: 2953987
    [Abstract] [Full Text] [Related]

  • 12. Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors.
    Ichihara K, Nabeshima T, Kameyama T.
    Eur J Pharmacol; 1992 Mar 24; 213(2):243-9. PubMed ID: 1355736
    [Abstract] [Full Text] [Related]

  • 13. In morphinised rats SKF 38393 converts dopamine D2 receptor-mediated forward locomotion into backward walking.
    Axon DI, Fletcher GH, Starr MS.
    Pharmacol Biochem Behav; 1987 Jan 24; 26(1):45-7. PubMed ID: 3494255
    [Abstract] [Full Text] [Related]

  • 14. Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.
    Molloy AG, Waddington JL.
    Psychopharmacology (Berl); 1984 Jan 24; 82(4):409-10. PubMed ID: 6427836
    [Abstract] [Full Text] [Related]

  • 15. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA, Widzowski DV, Newland MC.
    J Pharmacol Exp Ther; 1989 Sep 24; 250(3):800-8. PubMed ID: 2789282
    [Abstract] [Full Text] [Related]

  • 16. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Feb 24; 20(2):589-97. PubMed ID: 2953990
    [Abstract] [Full Text] [Related]

  • 17. Behavioural responses to the selective D1-dopamine receptor agonist R-SK&F 38393 and the selective D2-agonist RU 24213 in young compared with aged rats.
    Molloy AG, Waddington JL.
    Br J Pharmacol; 1988 Oct 24; 95(2):335-42. PubMed ID: 2906555
    [Abstract] [Full Text] [Related]

  • 18. Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats.
    Dall'Olio R, Gandolfi O, Vaccheri A, Roncada P, Montanaro N.
    Psychopharmacology (Berl); 1988 Oct 24; 95(3):381-5. PubMed ID: 2901128
    [Abstract] [Full Text] [Related]

  • 19. Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.
    Löschmann PA, Smith LA, Lange KW, Jaehnig P, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1991 Oct 24; 105(3):303-9. PubMed ID: 1686813
    [Abstract] [Full Text] [Related]

  • 20. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.